A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma

NCT05156268 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Carcinosarcoma

Interventions

DRUG: Pembrolizumab
DRUG: Olaparib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]